Search

Repligen Corp

Gesloten

SectorGezondheidszorg

166.1 -0.46

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

163.91

Max

167.8

Belangrijke statistieken

By Trading Economics

Inkomsten

-3.3M

5M

Verkoop

9.9M

204M

K/W

Sectorgemiddelde

223.521

57.002

EPS

0.54

Winstmarge

2.453

Werknemers

2,000

EBITDA

-35M

-2.4M

Aanbevelingen

By TipRanks

Aanbevelingen

Strong Buy

12 Maanden Prognose

+2.96% upside

Dividenden

By Acuity

Volgende Winsten

27 okt 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

1.8B

9.2B

Vorige openingsprijs

166.56

Vorige sluitingsprijs

166.1

Nieuwssentiment

By Acuity

50%

50%

163 / 340 Rangschikking in Healthcare

Repligen Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

14 aug 2026, 19:16 UTC

Repligen Corp shares are lower today amid a lack of specific news. Investor sentiment is cautious following a decline in U.S. retail sales.

13 aug 2026, 22:01 UTC

Repligen Corp shares are lower in after-market hours, dropping from a brief high. The price remains above its 20-day moving average.

12 aug 2026, 19:36 UTC

Repligen Corp shares are higher today amid broader market optimism following a modest increase in the core Consumer Price Index. No specific company news was identified.

11 aug 2026, 20:01 UTC

Repligen Corp shares are higher today, reflecting strong performance amid routine trading. The stock remains above its 20-day moving average.

10 aug 2026, 23:16 UTC

Repligen Corp shares are trading higher in after-market hours. The stock remains near the upper end of its one-month trading range.

7 aug 2026, 22:01 UTC

Repligen Corp shares are higher in after-market trading, continuing a trend of six consecutive sessions. Broader equity gains follow weaker employment data easing rate hike concerns.

6 aug 2026, 20:02 UTC

Repligen Corp shares are higher today, continuing gains from Wednesday. No specific company news was identified to explain the movement.

5 aug 2026, 20:02 UTC

Correlated Moves

Repligen Corp shares are higher today, bolstered by gains in Charles River Laboratories and positive sentiment in the life sciences sector.

4 aug 2026, 19:56 UTC

Repligen Corp shares are higher today, reflecting broader market strength amid a significant decline in crude oil prices. The stock is near its one-month range's upper end.

31 jul 2026, 20:02 UTC

Repligen Corp shares are lower today amid broader market pressures and rising US Treasury yields. The stock reached a session low earlier.

30 jul 2026, 21:02 UTC

Repligen Corp shares are higher in after-market trading, buoyed by positive investor sentiment amid a focus on corporate earnings and broader market trends.

29 jul 2026, 16:12 UTC

Repligen Corp shares are lower Wednesday, breaking a trend of higher daily closes. Broader market conditions reflect rising crude oil prices and inflation concerns.

28 jul 2026, 23:21 UTC

Repligen Corp shares are higher in after-market trading, reflecting strong momentum and trading near the upper end of its one-month range.

27 jul 2026, 16:26 UTC

News

Repligen Corporation shares are lower as the company approaches its Q2 earnings report, with analysts projecting 10.7% revenue growth. Current price is $131.96.

24 jul 2026, 19:06 UTC

News

Repligen Corp is under scrutiny as a stock to avoid, with concerns over its $763.3 million revenue and declining operating margins. Shares are trading lower today.

22 jul 2026, 19:25 UTC

News
Event
Social Media

Repligen Corp is acquiring BioLife Solutions for about $1.5 billion, offering $11.25 in cash and stock, with a projected $20 million in synergies.

21 jul 2026, 22:56 UTC

Repligen Corp shares are higher in after-market trading, despite a recent trend of lower closes. Broader market sentiment may be influenced by the Nikkei 225 surge.

20 jul 2026, 18:06 UTC

Repligen Corp shares are higher today, reflecting positive market sentiment despite earlier intraday fluctuations. No specific news was identified to explain the movement.

Peer Vergelijking

Prijswijziging

Repligen Corp Prognose

Koersdoel

By TipRanks

2.96% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 172.45 USD  2.96%

Hoogste 207 USD

Laagste 145 USD

Gebaseerd op 13 Wall Street-analisten die 12-maands prijsdoelen bieden voor Repligen Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Strong Buy

13 ratings

12

Buy

1

Hold

0

Sell

Sentiment

By Acuity

163 / 340 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Boven gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Repligen Corp

Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company's chromatography products include OPUS pre-packed chromatography columns, which are used in the purification of biologics; and OPUS smaller-scale columns that are used in the high throughput process development screening, viral clearance validation studies, and scale down validation of chromatography processes. It also offers ELISA test kits; and chromatography resins under the CaptivA brand. In addition, the company provides filtration products, such as XCell Alternating Tangential Flow systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; Spectra/Por laboratory and process dialysis products, and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems under the SoloVPE, FlowVPE, and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has collaboration agreements with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.
help-icon Live chat